Vetter Serializes First Product for South Korea

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-05-06-2015
Volume 11
Issue 5

CDMO Vetter produces identifiable labeling for a top-ten pharmaceutical company.

 

Vetter has announced that it has manufactured the first commercial batches with single-use identification numbers and implemented product serialization for secondary packaging in accordance with the requirements from the South Korean Ministry of Food and Drug Safety (MFDS). The Vetter solution identifies the drugs on the folding boxes via a 2-D data matrix code with a serial number, GTIN, expiry date, and batch number.

To combat counterfeit drugs, regulatory authorities worldwide are requiring clear identification of products through serialization; the smallest packaging unit must be marked with a single-use identification number. South Korea is among those countries requiring serialization with an aim towards protecting against counterfeiting, as well as a more secure supply chain.

Presently, South Korea has only asked for serialization on the folding package. China has legislated use of 1-D linear codes including aggregation with the shipping box.

Vetter provides services in secondary packaging, primary packaging, and final assembly to accommodate various regulatory or market needs. The company's serialization service includes a range of formats for serial numbers, different code systems, interfaces, and reports, as well as various aggregation depths.

Source: Vetter

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content